|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Prognostic Value of
TP53
Mutation for Transcatheter Arterial Chemo
embolization
Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma
Miao Xue, Yanqin Wu, Wenzhe Fan, Jian Guo, Jialiang Wei, Hongyu Wang, Jizhou Tan, Yu Wang, Wang Yao, Yue Zhao, Jiaping Li
Cancer Res Treat.
2020;52(3):925-937. Published online March 30, 2020 DOI:
https://doi.org/10.4143/crt.2019.533
Web of Science 9
Crossref 9
Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemo
embolization
Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su
Cancer Res Treat.
2018;50(2):530-537. Published online June 1, 2017 DOI:
https://doi.org/10.4143/crt.2017.156
Web of Science 22
Crossref 22
Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemo
embolization
Followed by Radiotherapy
Dongryul Oh, Sung Wook Shin, Hee Chul Park, Sung Ki Cho, Do Hoon Lim, Seung Woon Paik
Cancer Res Treat.
2015;47(2):251-258. Published online October 27, 2014 DOI:
https://doi.org/10.4143/crt.2014.011
Web of Science 14
Crossref 12
Pirarubicin, UFT, Leucovorin Chemotherapy in Non-embolizable and Transcatheter Arterial Chemo
embolization
-Failed Hepatocellular Carcinoma Patients; A Phase II Clinical Study
Kyong Hwa Park, So Young Yoon, Sang Cheul Oh, Jae Hong Seo, Chul Won Choi, Jong Eun Yeon, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Kwan Soo Byun, Jun Suk Kim, Chang Hong Lee
Cancer Res Treat.
2002;34(4):280-283. Published online August 31, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.4.280
Transarterial Chemo
embolization
( TACE ) for Hepatocellular carcinoma: Comparison of Adriamycin alone vs . Cisplatin alone vs . Adriamycin + Cisplatin
Jung Ae Lee, Keun Chil Park, Bong Seog Kim, Young Soo Do, Duk Lim, Tae Sung Park, Chang Min Kim, Jhin Oh Lee, Taik Koo Yun
J Korean Cancer Assoc.
1998;30(6):1156-1167.
Effect of Preoperative Transcatheter Arterial Chemo
embolization
on Recurrence Rate and Survival After Curative Resection in Patients with Hepatocellular Carcinoma
Dong Sup Yoon, Seung Ho Choi, Ki Whang Kim, Hoon Sang Chi, Byong Ro Kim
J Korean Cancer Assoc.
1996;28(4):726-733.
Studies on the pathological Changes of Human Hepatocellular Carcinomase and Their Cell Lines Induced by Adriamycin
Sang Yong Song, Chul Woo Kim, Woo Ho Kim, Chong Jai Kim, Gyeong Hoon Kang, Yong Il Kim
J Korean Cancer Assoc.
1996;28(4):611-622.
Intrahepatic Recurrence after Transhepatic Arterial Chemo
embolization
in Hepatocellular Carcinoma
Tae Yong Moon, Byung Soo Kim, Suck Hong Lee, Hak Jin Kim, Sung Yup Lim, Bong Sig Koo
J Korean Cancer Assoc.
1995;27(6):924-929.
1
Journal Impact Factor 4.6